Salt-inducible kinase inhibition suppresses acute myeloid leukemia progression in vivo
Yusuke Tarumoto(Kyoto University), Christopher R. Vakoc(Cold Spring Harbor Laboratory)
Cited by 81
Related Papers
Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated <i>Myc</i> regulation
|Genes & Development|2013|458
ETV6 dependency in Ewing sarcoma by antagonism of EWS-FLI1-mediated enhancer activation
|Nature Cell Biology|2023|34
MARK2/MARK3 Kinases Are Catalytic Codependencies of YAP/TAZ in Human Cancer
|Cancer Discovery|2024|24
IκBζ is a dual-use coactivator of NF-κB and POU transcription factors
|Molecular Cell|2024|13
The Salt-Inducible Kinase inhibitor YKL-05-099 suppresses MEF2C function and acute myeloid leukemia progression <i>in vivo</i>
|bioRxiv (Cold Spring Harbor Laboratory)|2019|1